Sequencing Builds Data Bridges to the Clinic
Searching for Innovative, Cost-Effective Product Options
Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
Goal Is the Development of Faster, More Affordable Therapies
When Success Rates Go Low, Cell-Based Screens Go High
To Boost Success Rates, Developers are Balancing High-Content and High-Throughput Screening
New Tack for Neurodegenerative Disease Research
Armed with New Tools and Lower Cost Sequencing, Researchers Take an Omics Approach to Neuro Diseases
For full access to this article login to GEN Select now.
SAFC Expands to Meet Customer Demands
Firm Focuses on Technology Upgrades and QA/QC for Increasingly Specialized Products
- Suppliers to the biotechnology market, like Sigma-Aldrich’s SAFC division, are kept on their toes by constantly evolving customer demands. As a result, vendors have built larger and larger catalogs of products, moving into complex and challenging areas over the years. Diversity has been a fundamental component of SAFC’s ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.